121 related articles for article (PubMed ID: 17303772)
21. Simvastatin Increases Fibulin-2 Expression in Human Coronary Artery Smooth Muscle Cells via RhoA/Rho-Kinase Signaling Pathway Inhibition.
Serra N; Rosales R; Masana L; Vallvé JC
PLoS One; 2015; 10(7):e0133875. PubMed ID: 26207907
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of angiotensin II-AT1 receptors during statin withdrawal in vascular smooth muscle cells.
Castejon AM; Zollner E; Tristano AG; Cubeddu LX
J Cardiovasc Pharmacol; 2007 Dec; 50(6):708-11. PubMed ID: 18091590
[TBL] [Abstract][Full Text] [Related]
23. HMG-CoA reductase inhibitor simvastatin mitigates VEGF-induced "inside-out" signaling to extracellular matrix by preventing RhoA activation.
Xu H; Zeng L; Peng H; Chen S; Jones J; Chew TL; Sadeghi MM; Kanwar YS; Danesh FR
Am J Physiol Renal Physiol; 2006 Nov; 291(5):F995-1004. PubMed ID: 16774905
[TBL] [Abstract][Full Text] [Related]
24. LDL induces parathyroid hormone-related protein expression in vascular smooth muscle cells: Modulation by simvastatin.
Martin-Ventura JL; Blanco-Colio LM; Aparicio C; Ortega L; Esbrit P; Egido J
Atherosclerosis; 2008 Jun; 198(2):264-71. PubMed ID: 18378243
[TBL] [Abstract][Full Text] [Related]
25. Esterified cholesterol accumulation induced by aggregated LDL uptake in human vascular smooth muscle cells is reduced by HMG-CoA reductase inhibitors.
Llorente-Cortés V; Martínez-González J; Badimon L
Arterioscler Thromb Vasc Biol; 1998 May; 18(5):738-46. PubMed ID: 9598832
[TBL] [Abstract][Full Text] [Related]
26. Prostacyclin induction by high-density lipoprotein (HDL) in vascular smooth muscle cells depends on sphingosine 1-phosphate receptors: effect of simvastatin.
González-Díez M; Rodríguez C; Badimon L; Martínez-González J
Thromb Haemost; 2008 Jul; 100(1):119-26. PubMed ID: 18612546
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of systemic sclerosis dermal fibroblast type I collagen production and gene expression by simvastatin.
Louneva N; Huaman G; Fertala J; Jiménez SA
Arthritis Rheum; 2006 Apr; 54(4):1298-308. PubMed ID: 16575855
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of autophagy by simvastatin through inhibition of Rac1-mTOR signaling pathway in coronary arterial myocytes.
Wei YM; Li X; Xu M; Abais JM; Chen Y; Riebling CR; Boini KM; Li PL; Zhang Y
Cell Physiol Biochem; 2013; 31(6):925-37. PubMed ID: 23817226
[TBL] [Abstract][Full Text] [Related]
29. HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo.
Han KH; Ryu J; Hong KH; Ko J; Pak YK; Kim JB; Park SW; Kim JJ
Circulation; 2005 Mar; 111(11):1439-47. PubMed ID: 15781755
[TBL] [Abstract][Full Text] [Related]
30. Simvastatin induces the apoptosis of normal vascular smooth muscle through the disruption of actin integrity via the impairment of RhoA/Rac-1 activity.
Kang S; Kim K; Noh JY; Jung Y; Bae ON; Lim KM; Chung JH
Thromb Haemost; 2016 Aug; 116(3):496-505. PubMed ID: 27306926
[TBL] [Abstract][Full Text] [Related]
31. Simvastatin reduces MMP-3 level in interleukin 1beta stimulated human chondrocyte culture.
Lazzerini PE; Capecchi PL; Nerucci F; Fioravanti A; Chellini F; Piccini M; Bisogno S; Marcolongo R; Laghi Pasini F
Ann Rheum Dis; 2004 Jul; 63(7):867-9. PubMed ID: 15194586
[TBL] [Abstract][Full Text] [Related]
32. Insulin-like growth factor-I induces reactive oxygen species production and cell migration through Nox4 and Rac1 in vascular smooth muscle cells.
Meng D; Lv DD; Fang J
Cardiovasc Res; 2008 Nov; 80(2):299-308. PubMed ID: 18567639
[TBL] [Abstract][Full Text] [Related]
33. Simvastatin modulates angiotensin II signaling pathway by preventing Rac1-mediated upregulation of p27.
Zeng L; Xu H; Chew TL; Chisholm R; Sadeghi MM; Kanwar YS; Danesh FR
J Am Soc Nephrol; 2004 Jul; 15(7):1711-20. PubMed ID: 15213258
[TBL] [Abstract][Full Text] [Related]
34. Statins suppress MMP2 secretion via inactivation of RhoA/ROCK pathway in pulmonary vascular smooth muscles cells.
Li M; Li Z; Sun X
Eur J Pharmacol; 2008 Sep; 591(1-3):219-23. PubMed ID: 18619957
[TBL] [Abstract][Full Text] [Related]
35. Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages.
Veillard NR; Braunersreuther V; Arnaud C; Burger F; Pelli G; Steffens S; Mach F
Atherosclerosis; 2006 Sep; 188(1):51-8. PubMed ID: 16321392
[TBL] [Abstract][Full Text] [Related]
36. Decreased C-reactive protein-induced resistin production in human monocytes by simvastatin.
Hu WL; Qiao SB; Li JJ
Cytokine; 2007 Dec; 40(3):201-6. PubMed ID: 18023360
[TBL] [Abstract][Full Text] [Related]
37. HMG-CoA reductase inhibitors reduce matrix metalloproteinase-9 activity in human varicose veins.
Nomura S; Yoshimura K; Akiyama N; Mikamo A; Furutani A; Aoki H; Matsuzaki M; Hamano K
Eur Surg Res; 2005; 37(6):370-8. PubMed ID: 16465063
[TBL] [Abstract][Full Text] [Related]
38. Simvastatin enhanced sodium nitroprusside-induced apoptosis of smooth muscle cells. An involvement of geranylgeraniol.
Fujita H; Shimotsuura S; Yanagisawa A; Morita I; Murota S; Ishikawa K
Atherosclerosis; 2000 Feb; 148(2):309-15. PubMed ID: 10657567
[TBL] [Abstract][Full Text] [Related]
39. Simvastatin inhibits C-reactive protein-induced pro-inflammatory changes in endothelial cells by decreasing mevalonate pathway products.
Liang YJ; Shyu KG; Wang BW; Lai LP
Cardiology; 2008; 110(3):182-90. PubMed ID: 18057884
[TBL] [Abstract][Full Text] [Related]
40. Simvastatin inhibits TGFβ1-induced fibronectin in human airway fibroblasts.
Schaafsma D; McNeill KD; Mutawe MM; Ghavami S; Unruh H; Jacques E; Laviolette M; Chakir J; Halayko AJ
Respir Res; 2011 Aug; 12(1):113. PubMed ID: 21864337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
